| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.281 | 4.143 | 6.330 | 11.875 | 17.264 | 16.645 | 17.542 |
| Total Income - EUR | - | - | - | 3.281 | 4.143 | 6.330 | 11.875 | 17.264 | 16.645 | 17.542 |
| Total Expenses - EUR | - | - | - | 2.323 | 3.354 | 4.662 | 10.692 | 14.831 | 15.380 | 15.681 |
| Gross Profit/Loss - EUR | - | - | - | 959 | 789 | 1.668 | 1.184 | 2.433 | 1.265 | 1.862 |
| Net Profit/Loss - EUR | - | - | - | 860 | 665 | 1.478 | 903 | 2.260 | 1.099 | 1.686 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medsan Optiluc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 288 | 254 | 3.746 | 3.395 | 3.406 | 2.997 | 2.584 |
| Current Assets | - | - | - | 2.978 | 2.672 | 2.041 | 1.170 | 3.532 | 4.778 | 7.242 |
| Inventories | - | - | - | 2.250 | 1.761 | 1.072 | 521 | 596 | 1.700 | 1.859 |
| Receivables | - | - | - | 0 | 0 | 41 | 20 | 0 | 0 | 0 |
| Cash | - | - | - | 728 | 911 | 928 | 629 | 2.936 | 3.078 | 5.383 |
| Shareholders Funds | - | - | - | 903 | 1.551 | 3.000 | 3.836 | 6.108 | 7.188 | 8.834 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.363 | 1.375 | 2.788 | 730 | 830 | 587 | 991 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Medsan Optiluc S.r.l.